BRCA2 and cancer: Polygenic risk scores (PRS) that combine the effects of multiple disease-associated single nucleotide polymorphisms (SNPs) provide marked cancer risk stratification in the general population (14,15) and BRCA1 and BRCA2 carriers (16–18).